Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.59 |
| ▸ | HTR2A | P28223 | 3/20 | 0.59 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.48 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.48 |
| ▸ | HRH1 | P35367 | 2/20 | 0.48 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.45 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.45 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.45 |
| ▸ | DPP4 | P27487 | 2/20 | 0.43 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.43 |
| ▸ | F2 | P00734 | 1/20 | 0.43 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.43 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10159564 | 1.00 | TAAR1 (0.59) | TAAR1HTR2ACHRNB2CHRNA4HRH1 | |
| Iodide SCHEMBL28728555 | 0.97 | TAAR1 (0.56) | TAAR1HTR2ACHRNB2CHRNA4HRH1 | |
| Hydrochloric Acid SCHEMBL4226728 | 0.97 | TAAR1 (0.56) | TAAR1HTR2ACHRNB2CHRNA4HRH1 | |
| SCHEMBL28587464 | 0.91 | TAAR1 (0.50) | TAAR1HTR2ACHRNB2CHRNA4HRH1 | |
| SCHEMBL5189954 | 0.80 | HRH1 (0.62) | TAAR1HTR2AHRH1SLC6A4SLC6A3 | |
| SCHEMBL22620835 | 0.80 | HRH1 (0.62) | TAAR1HTR2AHRH1SLC6A4SLC6A3 | |
| SCHEMBL4672668 | 0.80 | HRH1 (0.62) | TAAR1HTR2AHRH1SLC6A4SLC6A3 | |
| SCHEMBL6287110 | 0.80 | TAAR1 (0.48) | TAAR1HTR2ACHRNB2CHRNA4HRH1 | |
| Hydrochloric Acid SCHEMBL7970943 | 0.78 | HRH1 (0.60) | TAAR1HTR2ACHRNB2CHRNA4HRH1 | |
| SCHEMBL4126387 | 0.77 | TAAR1 (0.44) | TAAR1HTR2ACHRNB2CHRNA4HRH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 210 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120018406-A | Fine circuit pattern diffusion inhibitor and preparation method and application method thereof | 深圳市板明科技股份有限公司 | 2025-05-16 | — | — | CN | claimed |
| CN-119923165-A | Solar cell, preparation method thereof, photovoltaic module, system and power utilization device | 宁德时代新能源科技股份有限公司 | 2025-05-02 | — | — | CN | claimed |
| CN-118853145-A | Laser gain medium stable in air for long time and preparation method thereof | 电子科技大学长三角研究院(衢州) | 2024-10-29 | — | — | CN | claimed |
| CN-118614160-A | Perovskite solar cell, preparation method thereof and power utilization device | 宁德时代新能源科技股份有限公司 | 2024-09-06 | — | — | CN | claimed |
| CN-117859209-A | Perovskite solar cell and preparation method thereof | 宁德时代新能源科技股份有限公司 | 2024-04-09 | — | — | CN | claimed |
| CN-117442609-A | Application of tetrahydrocarbazole derivative in preventing and treating cow mastitis pathogenic bacteria | 兰州大学 | 2024-01-26 | — | — | CN | claimed |
| CN-117281120-A | Application of tetrahydrocarbazole derivative in preventing and controlling agricultural bacterial diseases | 兰州大学 | 2023-12-26 | — | — | CN | claimed |
| CN-117202748-A | Perovskite film and preparation method and application thereof | 上海科技大学 | 2023-12-08 | — | — | CN | claimed |
| WO-2023216132-A1 | PEROVSKITE SOLAR CELL AND PREPARATION METHOD THEREFOR | 宁德时代新能源科技股份有限公司 | 2023-11-16 | — | — | WO | claimed |
| CN-117015252-A | Solar cell with combined action of cesium salt and organic aromatic amine salt and preparation method thereof | 电子科技大学 | 2023-11-07 | — | — | CN | claimed |
| US-20070078146-A1 | Antiinflamamtory agents; antiarthritic agents; inflammatory bowel disorders; multiple sclerosis; asthma | PHARMACIA CORPORATION | 2007-04-05 | — | — | US | claimed |
| EP-1144403-B1 | SUBSTITUTED PYRAZOLES AS P38 KINASE INHIBITORS | SEARLE LLC (US) | 2004-10-06 | — | — | EP | claimed |
| US-20040176433-A1 | treatment of tumor necrosis factor mediated disorders; asthma; inflammatory bowel disease; arthritis | PHARMACIA CORPORATION | 2004-09-09 | — | — | US | claimed |
| US-6617324-B1 | Phenyl, cyclohexyl and pyridinyl or pyrimidinyl-substituted | G. D. SEARLE & COMPANY | 2003-09-09 | — | — | US | claimed |
| US-6514977-B1 | For treating p38 kinase mediated disorders | G.D. SEARLE & COMPANY | 2003-02-04 | — | — | US | claimed |
| US-6423713-B1 | Substituted pyrazoles as p38 kinase inhibitors | G. D. SEARLE & COMPANY | 2002-07-23 | — | — | US | claimed |
| EP-1144403-A1 | SUBSTITUED PYRAZOLES AS P38 KINASE INHIBITORS | G.D. SEARLE & CO. (US) | 2001-10-17 | — | — | EP | claimed |
| WO-2000031063-A1 | SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS | G.D. SEARLE & CO. (US) | 2000-06-02 | — | — | WO | claimed |
| EP-1000055-A1 | SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS | G.D. Searle & Co. (US) | 2000-05-17 | — | — | EP | claimed |
| WO-1998052940-A1 | SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS | G.D. SEARLE AND CO. (US) | 1998-11-26 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040176433-A1 | treatment of tumor necrosis factor mediated disorders; asthma; inflammatory bowel disease; arthritis | MAPK1, IL1R1, TNF | TAAR1 798/4885HTR2A 3942/4885CHRNB2 2978/4885 |
| US-20070078146-A1 | Antiinflamamtory agents; antiarthritic agents; inflammatory bowel disorders; multiple sclerosis; asthma | MAPK1, MAPK3, MAPK4 | TAAR1 1964/4885HTR2A 4042/4885CHRNB2 3880/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.